FIELD: cosmetics. SUBSTANCE: composition contains recombinating human polypeptide. Invention is based on application of small concentrations of factors of epidermal growth which is stabilized properly in high-molecular dextrin. Composition has γ-urogastron from 1 to 10 Hg/ml of composition and dextran 1-10 mg per mg of active principle. EFFECT: deceleration of skin ageing process. 2 cl, 1 dwg , 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTING ANTIBODIES TO TRANSGLUTAMINASE USABLE FOR DIAGNOSING CELIAC DISEASE | 2001 |
|
RU2214835C2 |
METHOD OF OBTAINING RECOMBINANT PROTEINS IN MAMMARY GLAND OF NON-TRANSGENIC MAMMALS | 2003 |
|
RU2345088C2 |
INTERLEUKINE-15 PEPTIDE ANTAGONIST | 2005 |
|
RU2396276C2 |
CR3 CHIMERA GENE AND CR3 CHIMERA PROTEIN ENCODED THEREWITH (VARIANTS) INDUCING ANTI-HIV-1 IMMUNE RESPONSE | 2002 |
|
RU2302461C2 |
RECOMBINANT CHIMERIC PROTEIN ANTH1, NUCLEIC ACID ENCODING ITS AND THEIR USING | 2003 |
|
RU2322455C2 |
ANTIBODY FRAGMENTS SPECIFIC IN RELATION TO HUMAN CANCER-EMBRYONIC ANTIGEN (CEA) | 2003 |
|
RU2294939C2 |
EGF/GHRP-6 COMBINATION FOR CENTRAL NERVOUS SYSTEM NEUROREGENERATION AFTER AUTOIMMUNNE DAMAGE | 2006 |
|
RU2403913C2 |
USING PHARMACEUTICAL COMPOSITION COMPRISING EPIDERMAL GROWTH FACTOR (EGF) FOR PREVENTION OF DIABETIC LIMB AMPUTATION | 2002 |
|
RU2289424C2 |
METHOD OF PREPARING SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG), MONOCLONAL ANTIBODIES CB-HEPI, SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG) AND METHOD OF PREPARING HYBRID CLONE 48/1/574 PRODUCING MONOCLONAL ANTIBODIES CB-HEPI | 1992 |
|
RU2128707C1 |
STABLE PHARMACEUTICAL COMPOSITIONS, CONTAINING GAMMA AND ALPHA INTERFERONS IN SYNERGIC RATIO | 2006 |
|
RU2403057C2 |
Authors
Dates
1998-06-10—Published
1994-07-05—Filed